VeChain (VET) at ‘Massively Strong Support’ as Analyst Eyes 300% Rally

- Analyst Michaël van de Poppe says VET is holding at a massively strong historical support zone now.
- A new “Stargate Staking” program offers up to 9% APY and is designed to make the VET token scarce.
- Key technical indicators like the RSI and MACD are flashing strong bullish signals for a price reversal.
VeChain (VET) is trading at a historically strong accumulation zone, as per analyst Michaël van de Poppe, who highlighted this fact in a social media post on X that VET is “holding onto massively strong support” with a valuation matching last year’s levels, despite several fundamental shifts in its ecosystem.
What takes the spotlight is the launch of VeChain’s Stargate Staking program, a move set to reduce inflation and create additional scarcity in VET’s tokenomics.
‘Stargate Staking’ to Bo…
The post VeChain (VET) at ‘Massively Strong Support’ as Analyst Eyes 300% Rally appeared first on Coin Edition.
Read More

Staked Injective ETF Filed by Canary Capital: Can INJ Reach $16?
VeChain (VET) at ‘Massively Strong Support’ as Analyst Eyes 300% Rally

- Analyst Michaël van de Poppe says VET is holding at a massively strong historical support zone now.
- A new “Stargate Staking” program offers up to 9% APY and is designed to make the VET token scarce.
- Key technical indicators like the RSI and MACD are flashing strong bullish signals for a price reversal.
VeChain (VET) is trading at a historically strong accumulation zone, as per analyst Michaël van de Poppe, who highlighted this fact in a social media post on X that VET is “holding onto massively strong support” with a valuation matching last year’s levels, despite several fundamental shifts in its ecosystem.
What takes the spotlight is the launch of VeChain’s Stargate Staking program, a move set to reduce inflation and create additional scarcity in VET’s tokenomics.
‘Stargate Staking’ to Bo…
The post VeChain (VET) at ‘Massively Strong Support’ as Analyst Eyes 300% Rally appeared first on Coin Edition.
Read More
